New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
Following a positive interim analysis showing that fractional flow-reserve-guided PCI was superior to optimal medical treatment, an independent Data and Safety Monitoring Board (DSMB) has recommended...
View ArticleSetback For Trial Studying Dabigatran After Mechanical Valve Surgery
Despite the recent advent of novel oral anticoagulants, the much-maligned warfarin remains the only current option available for patients who have received a mechanical valve. Now the first trial to...
View ArticleBoehringer Ends Phase 2 Trial Of Dabigatran In Mechanical Valve Patients
Boehringer Ingelheim today announced that it had discontinued a phase 2 trial of its anticoagulant drug dabigatran (Pradaxa) in patients with mechanical heart valves. As reported here in October, the...
View Article
More Pages to Explore .....